Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1963
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 2
1964 2
1965 2
1966 7
1967 1
1968 1
1969 5
1970 2
1971 4
1972 6
1974 4
1975 2
1976 2
1978 2
1979 3
1980 3
1981 3
1982 3
1984 1
1985 3
1987 1
1989 2
1990 2
1993 1
1994 2
1995 1
1996 5
1998 2
1999 1
2000 7
2001 3
2002 1
2004 1
2005 1
2006 3
2007 2
2008 1
2009 2
2010 1
2014 1
2015 1
2016 2
2017 1
2018 3
2019 4
2020 5
2021 2
2022 2
2023 6
2024 5
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

123 results

Results by year

Filters applied: . Clear all
Page 1
Laboratory Approach to Hemolytic Anemia.
Jamwal M, Sharma P, Das R. Jamwal M, et al. Indian J Pediatr. 2020 Jan;87(1):66-74. doi: 10.1007/s12098-019-03119-8. Epub 2019 Dec 10. Indian J Pediatr. 2020. PMID: 31823208 Review.
Hemolytic anemias are a group of disorders with varied clinical and molecular heterogeneity. ...The pathognomic finding is a reduced red cell life span with severe anemia or, compensated hemolysis accompanied by reticulocytosis. The diagnostic workup or laboratory a
Hemolytic anemias are a group of disorders with varied clinical and molecular heterogeneity. ...The pathognomic finding is a reduced
Glucose-6-phosphate dehydrogenase deficiency.
Cappellini MD, Fiorelli G. Cappellini MD, et al. Lancet. 2008 Jan 5;371(9606):64-74. doi: 10.1016/S0140-6736(08)60073-2. Lancet. 2008. PMID: 18177777 Review.
Some G6PD variants cause chronic haemolysis, leading to congenital non-spherocytic haemolytic anaemia. The most effective management of G6PD deficiency is to prevent haemolysis by avoiding oxidative stress. ...
Some G6PD variants cause chronic haemolysis, leading to congenital non-spherocytic haemolytic anaemia. The most effective management …
Management of pyruvate kinase deficiency in children and adults.
Grace RF, Barcellini W. Grace RF, et al. Blood. 2020 Sep 10;136(11):1241-1249. doi: 10.1182/blood.2019000945. Blood. 2020. PMID: 32702739 Free article. Review.
Pyruvate kinase deficiency (PKD) is an autosomal-recessive enzyme defect of the glycolytic pathway that causes congenital nonspherocytic hemolytic anemia. The diagnosis and management of patients with PKD can be challenging due to difficulties in the d …
Pyruvate kinase deficiency (PKD) is an autosomal-recessive enzyme defect of the glycolytic pathway that causes congenital nonspher
Congenital Hemolytic Anemia.
Haley K. Haley K. Med Clin North Am. 2017 Mar;101(2):361-374. doi: 10.1016/j.mcna.2016.09.008. Epub 2016 Dec 8. Med Clin North Am. 2017. PMID: 28189176 Review.
Red blood cell (RBC) destruction can be secondary to intrinsic disorders of the RBC or to extrinsic causes. In the congenital hemolytic anemias, intrinsic RBC enzyme, RBC membrane, and hemoglobin disorders result in hemolysis. ...For some congenital hemoly
Red blood cell (RBC) destruction can be secondary to intrinsic disorders of the RBC or to extrinsic causes. In the congenital hemo
Diagnosis and management of pyruvate kinase deficiency: international expert guidelines.
Al-Samkari H, Shehata N, Lang-Robertson K, Bianchi P, Glenthøj A, Sheth S, Neufeld EJ, Rees DC, Chonat S, Kuo KHM, Rothman JA, Barcellini W, van Beers EJ, Pospíšilová D, Shah AJ, van Wijk R, Glader B, Mañú Pereira MDM, Andres O, Kalfa TA, Eber SW, Gallagher PG, Kwiatkowski JL, Galacteros F, Lander C, Watson A, Elbard R, Peereboom D, Grace RF. Al-Samkari H, et al. Lancet Haematol. 2024 Mar;11(3):e228-e239. doi: 10.1016/S2352-3026(23)00377-0. Epub 2024 Feb 5. Lancet Haematol. 2024. PMID: 38330977 Review.
Pyruvate kinase (PK) deficiency is the most common cause of chronic congenital non-spherocytic haemolytic anaemia worldwide, with an estimated prevalence of one in 100 000 to one in 300 000 people. ...
Pyruvate kinase (PK) deficiency is the most common cause of chronic congenital non-spherocytic haemolytic anaemia worldwide, with an …
[Hereditary anaemias].
Glenthøj A. Glenthøj A. Ugeskr Laeger. 2021 Oct 18;183(42):V01210080. Ugeskr Laeger. 2021. PMID: 34709160 Free article. Review. Danish.
Updates and advances in pyruvate kinase deficiency.
Luke N, Hillier K, Al-Samkari H, Grace RF. Luke N, et al. Trends Mol Med. 2023 May;29(5):406-418. doi: 10.1016/j.molmed.2023.02.005. Epub 2023 Mar 17. Trends Mol Med. 2023. PMID: 36935283 Free PMC article. Review.
Mutations in the PKLR gene lead to pyruvate kinase (PK) deficiency, causing chronic hemolytic anemia secondary to reduced red cell energy, which is crucial for maintenance of the red cell membrane and function. ...Studies evaluating the role of PK activators in othe …
Mutations in the PKLR gene lead to pyruvate kinase (PK) deficiency, causing chronic hemolytic anemia secondary to reduced red …
Molecular heterogeneity of pyruvate kinase deficiency.
Bianchi P, Fermo E. Bianchi P, et al. Haematologica. 2020 Sep 1;105(9):2218-2228. doi: 10.3324/haematol.2019.241141. Haematologica. 2020. PMID: 33054047 Free PMC article. Review.
Red cell pyruvate kinase (PK) deficiency is the most common glycolytic defect associated with congenital non-spherocytic hemolytic anemia. The disease, transmitted as an autosomal recessive trait, is caused by mutations in the PKLR gene and is characterized b …
Red cell pyruvate kinase (PK) deficiency is the most common glycolytic defect associated with congenital non-spherocytic hemolytic
Glucose-6-phosphate isomerase deficiency.
Kugler W, Lakomek M. Kugler W, et al. Baillieres Best Pract Res Clin Haematol. 2000 Mar;13(1):89-101. doi: 10.1053/beha.1999.0059. Baillieres Best Pract Res Clin Haematol. 2000. PMID: 10916680 Review.
123 results